Drug transporters: recent advances concerning BCRP and tyrosine kinase inhibitors

被引：0
|
作者：
C Lemos
G Jansen
G J Peters
机构：
[1] VU University Medical Center,Department of Medical Oncology
[2] Faculty of Medicine,Department of Biochemistry (U38
[3] University of Porto,FCT)
[4] VU University Medical Center,Department of Rheumatology
来源：
British Journal of Cancer | 2008年 / 98卷
关键词：
BCRP; multidrug resistance; polymorphisms; stem cells; targeted therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Multidrug resistance is often associated with the (over)expression of drug efflux transporters of the ATP-binding cassette (ABC) protein family. This minireview discusses the role of one selected ABC-transporter family member, the breast cancer resistance protein (BCRP/ABCG2), in the (pre)clinical efficacy of novel experimental anticancer drugs, in particular tyrosine kinase inhibitors.
引用
收藏
页码：857 / 862
页数：5
相关论文
共 50 条
  • [1] Drug transporters: Recent advances concerning BCRP and tyrosine kinase inhibitors
    Lemos, C.
    Jansen, G.
    Peters, G. J.
    [J]. BRITISH JOURNAL OF CANCER, 2008, 98 (05) : 857 - 862
  • [2] Recent advances in tyrosine kinase inhibitors
    Fry, DW
    [J]. ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 31, 1996, 31 : 151 - 160
  • [3] Recent advances in metabolism and toxicity of tyrosine kinase inhibitors
    Zhao, Qi
    Wu, Zhanxuan E.
    Li, Bin
    Li, Fei
    [J]. PHARMACOLOGY & THERAPEUTICS, 2022, 237
  • [4] Recent advances in structure-based drug design and virtual screening of VEGFR tyrosine kinase inhibitors
    Hoi, Pui Man
    Li, Shang
    Vong, Chi Teng
    Tseng, Hisa Hui Ling
    Kwan, Yiu Wa
    Lee, Simon Ming-Yuen
    [J]. METHODS, 2015, 71 : 85 - 91
  • [5] Recent Advances in the Discovery of Multitargeted Tyrosine Kinase Inhibitors as Anticancer Agents
    Guo, Ting
    Ma, Shutao
    [J]. CHEMMEDCHEM, 2021, 16 (04) : 600 - 620
  • [6] Recent advances in the use of tyrosine kinase inhibitors against thyroid cancer
    Ferrari, Silvia Martina
    Patrizio, Armando
    Stoppini, Giulio
    Elia, Giusy
    Ragusa, Francesca
    Balestri, Eugenia
    Botrini, Chiara
    Rugani, Licia
    Barozzi, Emilio
    Mazzi, Valeria
    La Motta, Concettina
    Antonelli, Alessandro
    Fallahi, Poupak
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2024, 25 (12) : 1667 - 1676
  • [7] Restricted brain penetration of the tyrosine kinase inhibitor erlotinib due to the drug transporters P-gp and BCRP
    de Vries, Nienke A.
    Buckle, Tessa
    Zhao, Jin
    Beijnen, Jos H.
    Schellens, Jan H. M.
    van Tellingen, Olaf
    [J]. INVESTIGATIONAL NEW DRUGS, 2012, 30 (02) : 443 - 449
  • [8] Restricted brain penetration of the tyrosine kinase inhibitor erlotinib due to the drug transporters P-gp and BCRP
    Nienke A. de Vries
    Tessa Buckle
    Jin Zhao
    Jos H. Beijnen
    Jan H. M. Schellens
    Olaf van Tellingen
    [J]. Investigational New Drugs, 2012, 30 : 443 - 449
  • [9] Impact of Membrane Drug Transporters on Resistance to Small-Molecule Tyrosine Kinase Inhibitors
    Neul, Claudia
    Schaeffeler, Elke
    Sparreboom, Alex
    Laufer, Stefan
    Schwab, Matthias
    Nies, Anne T.
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2016, 37 (11) : 904 - 932
  • [10] The Role of Organic Cation Transporters in the Pharmacokinetics, Pharmacodynamics and Drug-Drug Interactions of Tyrosine Kinase Inhibitors
    Xiu, Fangrui
    Rausch, Magdalena
    Gai, Zhibo
    Su, Shanshan
    Wang, Shijun
    Visentin, Michele
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
12345